Analyst consensus rating
Astrana Health Analyst Rating: Strong Buy
Direct answer
Astrana Health's consensus rating is Strong Buy.
9 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $51.89.
Forecast evidence checked November 13, 2026.
Get free Astrana Health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.77
- Average price target
- $51.89
- High price target
- $65.00
- Low price target
- $45.00
- Low target gap
- +41.6%
- Target upside
- +63.3%
- High target gap
- +104.6%
- Target range width
- 63%
- Consensus rating
- Strong Buy
- Analysts
- 9
- Evidence date
- November 13, 2026
- Valid through
- November 20, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Astrana Health?
Astrana Health has a verified Strong Buy consensus. The same dataset has an average price target of $51.89.
How far are Astrana Health's low and high targets from the recorded price?
The low target implies +41.6%, while the high target implies +104.6%.
How many analysts are included in Astrana Health's consensus?
The verified consensus includes 9 analysts.
How is Astrana Health's target upside or downside calculated?
The average target of $51.89 is divided by the recorded price of $31.77, then one is subtracted to produce +63.3%. This does not guarantee a future return.
When was Astrana Health's analyst forecast verified?
The data was verified on 2026-11-13. The dataset is valid through 2026-11-20.